Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Investigating the Phase 3 Vivacity-MG3 clinical trial data on Nipocalimab in patients with myasthenia gravis.

Ticker(s): JNJ

Who's the expert?

Institution: Wayne State University

Assistant Professor in Neurology and Director of the Residency training program at Wayne State University.
Manages 500 patients with Multiple sclerosis.
Specializes in autoimmune neurological disorders including NMOSD, MOG antibody disease, Neurosarcoidosis, Myasthenia Gravis, Chronic inflammatory demyelinating polyneuropathy (CIDP), paraneoplastic disorders, and the neurologic complications of systemic autoimmune disorders such as Lupus and Sjogren's Syndrome.

Interview Goal

This call will feature a discussion on the current treatment landscape and the potential of Nipocalimab, a monoclonal antibody being developed by Johnson & Johnson for the treatment of myasthenia gravis.

Are You Interested In These Questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.